In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013).
In vitro activity of dalbavancin against multidrug-resistant Staphylococcus aureus and streptococci from patients with documented infections in Europe and surrounding regions (2011-2013). by Huband MD, Castanheira M, Farrell DJ, Flamm RK, Jones RN, Sader HS and Mendes RE published in Int. J. Antimicrob. Agents. 2016; 47 (6): 495-499
